Description
Product Overview / 商品概要
Amnolake Tablets 2mg (アムノレイク錠2mg)
Generic: Tamibarotene / タミバロテン
Therapeutic Category: Treatment agent for relapsed or refractory acute promyelocytic leukemia / 再発・難治性急性前骨髄球性白血病治療剤
Manufactured by: Toko Yakuhin Kogyo Co., Ltd. / 東光薬品工業株式会社
Composition & Specification / 組成・規格
Active Ingredient: Tamibarotene 2mg per tablet / 1錠中 タミバロテン 2mg
Additives: Lactose hydrate, Corn starch, Hydroxypropylcellulose, Magnesium stearate / 乳糖水和物、トウモロコシデンプン、ヒドロキシプロピルセルロース、ステアリン酸マグネシウム
Appearance: White uncoated tablet, diameter 7mm, thickness 3mm, weight 150mg, identification code 402
外観: 白色の素錠、直径7mm、厚さ3mm、質量150mg、識別コード402
Indications / 効能効果
EN: Relapsed or refractory acute promyelocytic leukemia (APL)
JA: 再発又は難治性の急性前骨髄球性白血病
Dosage and Administration / 用法用量
EN: Remission induction therapy: Administer 6mg/m²/day orally in 2 divided doses (morning and after dinner) until bone marrow remission is achieved. The treatment period must not exceed 8 weeks from the start of administration.
JA: 寛解導入療法:1日6mg/m²を2回にわけて朝、夕食後経口投与し、骨髄寛解が得られるまで投与する。投与期間は本剤の投与開始日から8週間を越えないこと。
Contraindications / 禁忌
EN: Pregnant women or women who may be pregnant; patients with a history of hypersensitivity to any component of this product; patients receiving vitamin A preparations; patients with hypervitaminosis A
JA: 妊婦又は妊娠している可能性のある女性、本剤の成分に対し過敏症の既往歴のある患者、ビタミンA製剤を投与中の患者、ビタミンA過剰症の患者
Regulatory Information / 規制情報
Approval No.: 21700AMZ00597000
Sales Started: June 2005 / 2005年6月
Classification Code: 874291
Storage: Store at room temperature / 室温保存
Shelf Life: 2 years / 2年
Packaging / 包装
Main Package (for sale): 10 tablets x 1 (aluminum pillow packaging) / 10錠×1(アルミピロー包装)
Other Available Packages (by special order): PTP: 10 tablets [10 tablets x 1: aluminum pillow packaging]
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.